⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ILMN

Illumina, Inc.

Healthcare · Diagnostics & Research

269.42USD

+0.0200 (+0.01%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ILMN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 269.42
P/E49.3
Dvd Ind Yld0.0%
P/B14.33
P/S9.1
Curr EV/T12M EBITDA37.6
Mkt Cap (USD)40.7B
Curr EV (USD)42.0B
2)

Per Share Data

EPS T12M5.36
DPS—
Bk Val Per Sh18.80
Rev/Sh29.37
Cash/Sh7.74
Curr Shares Out151.0M
FCF/Sh6.08
3)

Cash Flow Analysis

P/CF37.2
Curr P/FCF43.7
CF/NI1.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales24.4%
Eff Interest Rate12.1%
4)

Growth Potential

Dil EPS 1Y Gr170.9%
Cap 1Y Gr14.7%
BPS 1Y Gr17.0%
R&D To Sales21.4%
Retention Rate100.0%
Rev 1Y Gr-0.7%
FCF 1Y Gr31.3%
Assets 1Y Gr5.4%
5)

Profitability

EBITDA1.1B
EBIT0.9B
Operating Margin19.6%
Pretax Margin22.6%
Net Margin18.4%
ROA13.0%
ROE32.4%
ROC17.9%
Asset Turnover0.71
6)

Structure

Current Ratio1.80
Quick Ratio1.25
Debt/Assets17.5%
Debt/Com Eq41.1%
Net Debt/EBITDA0.11
Tot Debt/Capital29.1%
Gross Margin66.4%
EBIT/Int Exp8.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.